Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights

SAN DIEGO--(BUSINESS WIRE)--Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and RareVision mark a significant leap forward in genetic diagnostics as they capture not only commonly known mutations, but also rare and complicated mutations that are often missed by other types of genetic testing like traditional pa